ArticleEuropean radiology2023
Ovarian imaging radiomics quality score assessment: an EuSoMII radiomics auditing group initiative.
Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Accuracy of Radiomics-Based Machine Learning for Predicting Risk of Recurrence in Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
- Evaluating the quality of radiomics-based studies for endometrial cancer using RQS and METRICS tools.European radiology · 2025Pooled it
- Radiomics for the identification of extraprostatic extension with prostate MRI: a systematic review and meta-analysis.European radiology · 2024Pooled it
- Application of magnetic resonance imaging radiomics in endometrial cancer: a systematic review and meta-analysis.La Radiologia medica · 2024Pooled it
- Current status and quality of radiomics studies for predicting outcome in acute ischemic stroke patients: a systematic review and meta-analysis.Frontiers in neurology · 2023Pooled it
- Reproducibility of radiomics quality score: an intra- and inter-rater reliability study.European radiology · 2024Trial
- Reproducibility of methodological radiomics score (METRICS): an intra- and inter-rater reliability study endorsed by EuSoMII.European radiology · 2025Article
- A nomogram combining clinical features, O-RADS US, and radiomics based on ultrasound imaging for diagnosing ovarian cancer.Scientific reports · 2025Article
- Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing group initiative.European radiology · 2025Review
- More than meets the eye: 2-[European journal of nuclear medicine and molecular imaging · 2024Article
- Radiomics Applications in Spleen Imaging: A Systematic Review and Methodological Quality Assessment.Diagnostics (Basel, Switzerland) · 2023Review
- A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility.Insights into imaging · 2023Review
- An overview of meta-analyses on radiomics: more evidence is needed to support clinical translation.Insights into imaging · 2023Article
- Radiomics Analysis for Multiple Myeloma: A Systematic Review with Radiomics Quality Scoring.Diagnostics (Basel, Switzerland) · 2023Review
- Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review.Exploration of targeted anti-tumor therapy · 2023Review
- A first look into radiomics application in testicular imaging: A systematic review.Frontiers in radiology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the methodological rigor of radiomics-based studies using noninvasive imaging in ovarian setting.
methodsMultiple medical literature archives (PubMed, Web of Science, and Scopus) were searched to retrieve original studies focused on computed tomography (CT), magnetic resonance imaging (MRI), ultrasound (US), or positron emission tomography (PET) radiomics for ovarian disorders' assessment. Two researchers in consensus evaluated each investigation using the radiomics quality score (RQS). Subgroup analyses were performed to assess whether the total RQS varied according to first author category, study aim and topic, imaging modality, and journal quartile.
resultsFrom a total of 531 items, 63 investigations were finally included in the analysis. The studies were greatly focused (94%) on the field of oncology, with CT representing the most used imaging technique (41%). Overall, the papers achieved a median total RQS 6 (IQR, -0.5 to 11), corresponding to a percentage of 16.7% of the maximum score (IQR, 0-30.6%). The scoring was low especially due to the lack of prospective design and formal validation of the results. At subgroup analysis, the 4 studies not focused on oncological topic showed significantly lower quality scores than the others.
conclusionsThe overall methodological rigor of radiomics studies in the ovarian field is still not ideal, limiting the reproducibility of results and potential translation to clinical setting. More efforts towards a standardized methodology in the workflow are needed to allow radiomics to become a viable tool for clinical decision-making. KEY POINTS: • The 63 included studies using noninvasive imaging for ovarian applications were mostly focused on oncologic topic (94%). • The included investigations achieved a median total RQS 6 (IQR, -0.5 to 11), indicating poor methodological rigor. • The RQS was low especially due to the lack of prospective design and formal validation of the results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.